Wei Cui
Impact in
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
- MicroRNA in disease regulation
- Hematology top 5%
- Acute Myeloid Leukemia Research
Papers in
- Oncology 26
- Cancer Cells and Metastasis 8
- Co-authors
- Diane L. Persons (4 shared papers)Jill C. Pelling (2 shared papers)Eugenia M. Yazlovitskaya (2 shared papers)Bryan L. Copple (3 shared papers)James P. Luyendyk (3 shared papers)Chunfu Wu (3 shared papers)Jessica A. Williams (1 shared paper)Hong-Min Ni (1 shared paper)
- Journals
- Blood (4 papers)American Journal of Clinical Pathology (3 papers)Modern Pathology (2 papers)Oncotarget (2 papers)Journal of Hepatology (2 papers)
- Partner nations
- United StatesChinaUnited Kingdom
In The Last Decade
Wei Cui
85 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 107
- Cancer Research 298
- Hematology 221
- Oncology 472
- Molecular Biology 825
- Pathology and Forensic Medicine 188
Countries citing papers authored by Wei Cui
This map shows the geographic impact of Wei Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Cui more than expected).
Fields of papers citing papers by Wei Cui
This network shows the impact of papers produced by Wei Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Cui. The network helps show where Wei Cui may publish in the future.
Co-authors
The 25 scholars most cited alongside Wei Cui, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 89 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 222 | |
| 2 | Cisplatin-induced activation of mitogen-activated protein kinases in ovarian carcinoma cells: inhibition of extracellular signal-regulated kinase activity increases sensitivity to cisplatin. | 1999 | 222 |
| 3 | 2020 | 147 | |
| 4 | 2013 | 110 | |
| 5 | 2016 | 90 | |
| 6 | 2013 | 79 | |
| 7 | 2000 | 69 | |
| 8 | 2011 | 63 | |
| 9 | 2019 | 48 | |
| 10 | 2017 | 48 | |
| 11 | 2022 | 46 | |
| 12 | 2021 | 44 | |
| 13 | 2016 | 44 | |
| 14 | 2021 | 41 | |
| 15 | 2018 | 41 | |
| 16 | Aldehyde dehydrogenase 1A1 circumscribes high invasive glioma cells and predicts poor prognosis. | 2015 | 41 |
| 17 | 2012 | 36 | |
| 18 | 2010 | 30 | |
| 19 | 2020 | 30 | |
| 20 | 2013 | 29 |
About Wei Cui
Wei Cui is a scholar working on Oncology, Molecular Biology, Hematology, Genetics and Immunology, having authored 89 papers that have together received 1.9k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (11 papers), Multiple Myeloma Research and Treatments (10 papers), Cancer Cells and Metastasis (8 papers), Lymphoma Diagnosis and Treatment (7 papers), Autophagy in Disease and Therapy (6 papers), Glioma Diagnosis and Treatment (5 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers). The work is most often cited by research in Cancer Research (298 citations), Hematology (221 citations), Oncology (472 citations), Molecular Biology (825 citations) and Pathology and Forensic Medicine (188 citations). Wei Cui has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include Diane L. Persons, Jill C. Pelling, Eugenia M. Yazlovitskaya, Bryan L. Copple, James P. Luyendyk, Chunfu Wu, Jessica A. Williams, Hong-Min Ni, Wen-Xing Ding and Hartmut Jaeschke. Their work appears in journals such as Blood, American Journal of Clinical Pathology, Modern Pathology, Oncotarget and Journal of Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.